A possible role of lncRNA MEG3 and lncRNA MAFG-AS1 on miRNA 147-b in the pathogenesis of Behcet’s disease

Ahmadi M, Morshedzadeh F, Ghaderian S, Mousavi P, Habibipour L, Peymani M, Abbaszadegan M, Ghafouri-Fard S (2023) Carcinogenic roles of MAFG-AS1 in human cancers. Clin Transl Oncol 26(1):52–68. https://doi.org/10.1007/s12094-023-03246-x

Article  PubMed  CAS  Google Scholar 

Atas N, Varan O, Babaoglu H, Satis H, Bilici Salman R, Celik B, Tufan A, Haznedaroglu S, Goker B, Ozturk M (2019) Work productivity in patients with Behçet disease and its association with disease activity and quality of life. Br J Occup Ther 82(6):376–382. https://doi.org/10.1177/0308022619834184

Article  Google Scholar 

Aydındoğan S, Velioğlu E, Hakkı S (2023) Behçet’s disease and periodontal disease. Curr Oral Health Rep 10(2):52–58. https://doi.org/10.1007/s40496-023-00332-5

Article  Google Scholar 

Bettiol A, Alibaz-Oner F, Direskeneli H, Hatemi G, Saadoun D, Seyahi E, Prisco D, Emmi G (2023) Vascular Behçet syndrome: From pathogenesis to treatment. Nat Rev Rheumatol 19(2):111–126. https://doi.org/10.1038/s41584-022-00880-7

Article  PubMed  CAS  Google Scholar 

Cui S, Yang X, Zhang L, Zhao Y, Yan W (2018) LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4. Biochem Biophys Res Commun 506(1):251–258. https://doi.org/10.1016/j.bbrc.2018.10.112

Article  PubMed  CAS  Google Scholar 

Dabbaghi K, Mashatan N, Faraz O, Bashkandi A, Shomoossi N, Tabnak P (2023) A review on the roles and molecular mechanisms of MAFG-AS1 in oncogenesis. Pathol Res Pract 154348. https://doi.org/10.1016/j.prp.2023.154348

Davatchi F, Assaad-Khalil S, Calamia K, Crook J, Sadeghi-Abdollahi B, Schirmer M, Tzellos T, Zouboulis C, Akhlagi M, Al-Dalaan A, Alekberova Z, Ali A, Altenburg A, Arromdee E, Baltaci M, Bastos M, Benamour S, Ben Ghorbel I, Boyvat A, Ziaei N (2014) The International Criteria for Behçet’s Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28(3):338–347. https://doi.org/10.1111/jdv.12107

Article  Google Scholar 

Dong Y, Feng S, Dong F (2020) Maternally-expressed gene 3 (MEG3)/miR-143-3p regulates injury to periodontal ligament cells by mediating the AKT/inhibitory κB kinase (IKK) pathway. Med Sci Monit. https://doi.org/10.12659/MSM.922486

Article  PubMed  PubMed Central  Google Scholar 

Elsherbeny M, Elsergany A, Shaker O (2023) Association of lncRNA MEG3 Rs7158663 polymorphism and serum expression with colorectal cancer in Egyptian patients. Rep Biochem Mol Biol 12(1):102–111. https://doi.org/10.52547/rbmb.12.1.102

Article  CAS  Google Scholar 

Gao Z, Zheng G, Gong X, Hu H, Shao L, Pang Y, Wang Y, Qi A (2022) LncRNA MAFG-AS1 deregulated in breast cancer affects autophagy and progression of breast cancer by interacting with miR-3612 and FKBP4 in vitro. Biochem Biophys Res Commun 616:95–103. https://doi.org/10.1016/j.bbrc.2022.05.020

Article  PubMed  CAS  Google Scholar 

Greco A, De Virgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, de Vincentiis M, Lambiase A (2018) Behçet’s disease: New insights into pathophysiology, clinical features and treatment options. Autoimmun Rev 17(6):567–575. https://doi.org/10.1016/j.autrev.2017.12.006

Article  PubMed  CAS  Google Scholar 

Gu F, Huang X, Huang W, Zhao M, Zheng H, Wang Y, Chen R (2023) The role of miRNAs in Behçet’s disease. Front Immunol. https://doi.org/10.3389/fimmu.2023.1249826

Article  PubMed  PubMed Central  Google Scholar 

Huang X, Zhang W, Pu F, Zhang Z (2023a) LncRNA MEG3 promotes chemosensitivity of osteosarcoma by regulating antitumor immunity via miR-21-5p/p53 pathway and autophagy. Genes & Diseases 10(2):531–541. https://doi.org/10.1016/j.gendis.2021.11.004

Article  CAS  Google Scholar 

Huang Z, Zhang M, Li J, Lou C (2023b) Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers. Biomed Pharmacother 163. https://doi.org/10.1016/j.biopha.2023.114756

Article  PubMed  CAS  Google Scholar 

Konstantinidis A, Pardali D, Adamama-Moraitou K, Gazouli M, Dovas C, Legaki E, Brellou G, Savvas I, Jergens A, Rallis T, Allenspach K (2020) Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease. BMC Vet Res 16(1):69. https://doi.org/10.1186/s12917-020-02287-6

Article  PubMed  CAS  Google Scholar 

Lawton G (2004) The Behcet’s disease activity index. Rheumatology 43(1):73–78. https://doi.org/10.1093/rheumatology/keg453

Article  PubMed  CAS  Google Scholar 

Li Z, Yang L, Liu X, Wang X, Pan Y, Luo J (2018) The long noncoding RNA MEG3 and its target miR-147 regulate JAK/STAT pathway in advanced chronic myeloid leukemia. EBioMedicine 34:61–75. https://doi.org/10.1016/j.ebiom.2018.07.013

Article  PubMed  PubMed Central  Google Scholar 

Li P, Shi Y, Guo M, Xu H, Zhan M, Wang Z, Chen Y (2022) MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression. Front Oncol. https://doi.org/10.3389/fonc.2022.856580

Article  PubMed  PubMed Central  Google Scholar 

Li K, Gong Q, Xiang X, Guo G, Liu J, Zhao L, Li J, Chen N, Li H, Zhang L, Zhou C, Wang Z, Zhuang L (2023) HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis. J Transl Med 21(1):382. https://doi.org/10.1186/s12967-023-04190-8

Article  PubMed  PubMed Central  CAS  Google Scholar 

Limthongkul J, Mapratiep N, Apichirapokey S, Suksatu A, Midoeng P, Ubol S (2019) Insect anionic septapeptides suppress DENV replication by activating antiviral cytokines and miRNAs in primary human monocytes. Antiviral Res 168:1–8. https://doi.org/10.1016/j.antiviral.2019.04.012

Article  PubMed  CAS  Google Scholar 

Lin L, Hu K (2021) MiR-147: Functions and implications in inflammation and diseases. MicroRNA 10(2):91–96. https://doi.org/10.2174/2211536610666210707113605

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu G, Friggeri A, Yang Y, Park Y, Tsuruta Y, Abraham E (2009) miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci 106(37):15819–15824. https://doi.org/10.1073/pnas.0901216106

Article  PubMed  PubMed Central  Google Scholar 

Liu C, Liang T, Zhang Z, Chen J, Xue J, Zhan X, Ren L (2023) MEG3 alleviates ankylosing spondylitis by suppressing osteogenic differentiation of mesenchymal stem cells through regulating microRNA-125a-5p-mediated TNFAIP3. Apoptosis 28(3–4):498–513. https://doi.org/10.1007/s10495-022-01804-2

Article  PubMed  CAS  Google Scholar 

Lu Y, Qie D, Yang F, Wu J (2023) LncRNA MEG3 aggravates adipocyte inflammation and insulin resistance by targeting IGF2BP2 to activate TLR4/NF-κB signaling pathway. Int Immunopharmacol 121. https://doi.org/10.1016/j.intimp.2023.110467

Article  PubMed  CAS  Google Scholar 

Marinello D, Palla I, Lorenzoni V, Andreozzi G, Pirri S, Ticciati S, Cannizzo S, Del Bianco A, Ferretti E, Santoni S, Turchetti G, Mosca M, Talarico R (2023) Exploring disease perception in Behçet’s syndrome: combining a quantitative and a qualitative study based on a narrative medicine approach. Orphanet J Rare Dis 18(1):58. https://doi.org/10.1186/s13023-023-02668-8

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mehana N, Ghaiad H, Hassan M, Elsabagh Y, Labib S, Abd-Elmawla M (2022) LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Behçet’s disease and systemic lupus erythematosus. Life Sci 309. https://doi.org/10.1016/j.lfs.2022.120965

Article  PubMed  CAS  Google Scholar 

Pan X, He L (2020) LncRNA MEG3 expression in sepsis and its effect on LPS-induced macrophage function. Cell Mol Biol 66(5):131–136. https://doi.org/10.14715/cmb/2020.66.5.23

Article  PubMed  Google Scholar 

Perazzio SF, Allenspach EJ, Eklund KK, Varjosalo M, Shinohara MM, Torgerson TR, Seppänen MRJ (2020) Behçet disease (BD) and BD‐like clinical phenotypes: NF‐κB pathway in mucosal ulcerating diseases. Scand J Immunol 92(5). https://doi.org/10.1111/sji.12973

Posarelli C, Maglionico M, Talarico R, Covello G, Figus M (2020) Behçet’s syndrome and ocular involvement: Changes over time. Clin Exp Rheumatol 38 Suppl 127(5):86–93

PubMed 

留言 (0)

沒有登入
gif